TSS
PSTV

Two Sigma Securities’s Plus Therapeutics PSTV Stock Holding History

Two Sigma Securities’s Portfolio PSTV Stock Details PSTV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$23.2K Buy
5,712
+3,477
+156% +$26.4K ﹤0.01% 1355
2025
Q4 		$28.6K Buy
2,235
+1,792
+405% +$27K ﹤0.01% 1132
2025
Q3 		$7.57K Buy
+443
New +$5.44K ﹤0.01% 1236
2025
Q2 		– Sell
-544
Closed -$12.9K – 1967
2025
Q1 		$12.9K Sell
544
-39
-7% -$1.09K ﹤0.01% 1179
2024
Q4 		$16.8K Buy
+583
New +$18.7K ﹤0.01% 1348
2023
Q2 		– Sell
-63
Closed -$6.8K – 3230
2023
Q1 		$6.8K Sell
63
-46
-42% -$6.19K ﹤0.01% 2499
2022
Q4 		$12.9K Sell
109
-62
-36% -$9.87K ﹤0.01% 2327
2022
Q3 		$29K Buy
+171
New +$38.2K ﹤0.01% 2257
2022
Q1 		– Sell
-37
Closed -$15K – 2426
2021
Q4 		$15K Buy
+37
New +$21.3K ﹤0.01% 1440
2017
Q4 		– Hold
0
– -$6K – 1951
2017
Q3 		– Hold
0
– – – 879
2017
Q2 		– Hold
0
– – – 704
2015
Q2 		– Hold
0
– -$32K – 245
2015
Q1 		– Hold
0
– – – 162

Other funds holding PSTV

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Two Sigma Securities's PSTV Position: Q1 2026 in Review

Two Sigma Securities increased its Plus Therapeutics (PSTV) stake by 156% in Q1 2026, buying an estimated $26.4K and bringing the position to 5,712 shares worth $23.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1355.

Two Sigma Securities first reported a position in PSTV in Q4 2021 and has held it in 9 quarters since. The position peaked at $29K in Q3 2022. 23 funds tracked by Wall St. Rank hold PSTV as of Q1 2026.

  • Two Sigma Securities held 5,712 shares of Plus Therapeutics worth $23.2K as of Q1 2026.
  • Two Sigma Securities bought 3,477 Plus Therapeutics shares in Q1 2026, an estimated $26.4K.
  • Plus Therapeutics made up ﹤0.01% of Two Sigma Securities's portfolio in Q1 2026, its #1355 holding.
  • Two Sigma Securities first reported a position in Plus Therapeutics in Q4 2021 and has held it in 9 quarters since.
  • Two Sigma Securities's Plus Therapeutics position peaked at $29K in Q3 2022.
  • 23 funds tracked by Wall St. Rank held Plus Therapeutics as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.